Recent developments with BioXcel Therapeutics Inc (BTAI) have led to the company’s beta value being reach -0.00 cents.
On Tuesday, BioXcel Therapeutics Inc (NASDAQ: BTAI) was 4.07% up from the session before settling in for the closing price of $0.34. A 52-week range